Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses

BACKGROUND: The airway epithelium (AE) forms the first line of defence against harmful particles and pathogens. Barrier failure of the airway epithelium contributes to exacerbations of a range of lung diseases that are commonly treated with Azithromycin (AZM). In addition to its anti-bacterial funct...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Res
Autors principals: Joelsson, Jon Petur, Kricker, Jennifer A., Arason, Ari J., Sigurdsson, Snaevar, Valdimarsdottir, Bryndis, Gardarsson, Fridrik Runar, Page, Clive P., Lehmann, Fredrik, Gudjonsson, Thorarinn, Ingthorsson, Saevar
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488110/
https://ncbi.nlm.nih.gov/pubmed/32912304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01489-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars